Read More

Brazil’s PagSeguro Digital Gets A Boost: Goldman Sachs Upgrades Stock, Forecasts Stronger 2024 Growth

Goldman Sachs' Tito Labarta upgrades PagSeguro (PAGS) to Neutral, setting a bullish tone with a raised price target of $13.8. Anticipate sustained low double-digit Total Payment Volume (TPV) growth in 2024, boosting revenue. Labarta foresees improved net margins due to declining interest rates and controlled expenses, positioning PagSeguro for growth in its loan book and deposit base.

PAGS

Read More

Rails Back On Track: Analyst Upgrades Union Pacific And Norfolk Southern, Predicts Strong Intermodal Recovery

Analyst David Vernon forecasts a positive trajectory for U.S. rail stocks in FY24. Navigate the evolving market with strategic upgrades: Union Pacific Corp (UNP) and Norfolk Southern Corp (NSC). UNP stands out as a top-quality investment, upgraded to Outperform, while NSC gains momentum with an Outperform rating and a compelling turnaround narrative.

CSX

Read More

Sector Shifts: Bank of America Analyst Forecasts Challenging 2024 for Machinery, Downgrades Cummins and GFL, Upgrades PACCAR

BofA Securities' Michael Feniger adjusts ratings for machinery and energy companies, anticipating challenges in the machinery sector due to slow backlogs and moderating pricing. The analyst downgrades GFL Environmental and Cummins but upgrades PACCAR, reflecting a nuanced outlook amid expectations of a tightening cycle and global economic shifts.

CMI

Read More

Heart Devices Focused Silk Road Medical Stock Gets an Upgrade – Analyst Says New CEO’s Initiatives Sets Stage For ‘Back On Track’

Stifel's upgraded outlook on Silk Road Medical as CEO Chas McKhann addresses concerns, unveils a compelling vision, and outlines strategic initiatives. Analysts upgrade to Buy with $20 price target, citing confidence in TCAR technology and long-term growth under McKhann's leadership.

SILK